オプションチェーンは、Unusual Machinesの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Unusual Machinesの市場センチメントを評価します。.

Unusual Machines (AMEX:UMAC) 株価情報, オプションチェーン

Unusual Machines

Unusual Machines Inc is a development stage technology company.

Unusual Machines Inc

Better Choice Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTTR#NYSE">BTTR</a>) ("Better Choice" or the "Company"), a pet health and wellness company, announced today that SRx Health Solutions, Inc. ("SRx") was granted the final Order pursuant to the Business Corporations Act by the Ontario Superior Court of Justice to proceed with the acquisition by Better Choice Company.

BTTR

Better Choice Company Announces That SRx Health Solutions Was Granted The Final Order Pursuant To The Business Corporations Act By The Ontario Superior Court Of Justice To Proceed With The Acquisition By Better Choice Company

WIIM

SUNE

SUNation Energy shares are trading lower after the company announced the initial closing of registered direct offering generation gross proceeds of $15 million.

Herc Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRI#NYSE">HRI</a>) short percent of float has fallen 11.83% since its last report. The company recently reported that it has 954 thousand shares sold short, which is 3.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Herc Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740757531_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Herc Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Herc Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Herc Holdings's peer group average for short interest as a percentage of float is 5.27%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Is Herc Holdings Gaining or Losing Market Support?

Goldman Sachs Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) short percent of float has risen 10.07% since its last report. The company recently reported that it has 4.76 million shares sold short, which is 1.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.12 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Goldman Sachs Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740757525_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Goldman Sachs Gr has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Goldman Sachs Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Goldman Sachs Gr's peer group average for short interest as a percentage of float is 3.30%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Goldman Sachs Gr's Recent Short Interest

Interactive Brokers Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NYSE">IBKR</a>) short percent of float has risen 3.59% since its last report. The company recently reported that it has 2.44 million shares sold short, which is 2.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.29 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Interactive Brokers Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740757519_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Interactive Brokers Gr has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Interactive Brokers Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Interactive Brokers Gr's peer group average for short interest as a percentage of float is 3.27%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

IBKR

Is Interactive Brokers Gr Gaining or Losing Market Support?

Craig-Hallum analyst Alex Fuhrman maintains Life Time Group Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTH#NYSE">LTH</a>) with a Buy and raises the price target from $40 to $45.

News

Price Target

Analyst Ratings

Craig-Hallum Maintains Buy on Life Time Group Hldgs, Raises Price Target to $45

Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares are moving lower on continued volatility on Friday following the company&#8217;s quarterly report filing with the U.S. Securities <a href="https://www.benzinga.com//node/43960671">and Exchange Commission.</a>
What To Know: Earlier this week, the company filed its second-quarter earnings after a long delay triggered by the resignation of its former auditor, Ernst &amp; Young, over internal control issues. It also filed its fiscal-year 2024 results and first-quarter earnings this week.
Super Micro managed to file its earnings just before Nasdaq&#8217;s Tuesday deadline, which the company risked de-listing from the index if it missed. Shares originally traded higher during Tuesday&#8217;s after-hours session and into Wednesday.
The server manufacturing company reported second-quarter earnings per share of 54 cents, missing analysts&#8217; estimate of 64 cents. It reported revenue of $5.68 billion, missing analysts&#8217; estimate of $5.87 billion.
An independent committee-led investigation found no signs of fraud involving the company&#8217;s management or board. Super Micro hired BDO as its new financial auditor. 
In an explanatory note in Tuesday&#8217;s filing, the company stated, "We disagreed with EY&#8217;s decision to resign as our independent registered public accounting firm for a number of reasons … Due to EY&#8217;s stated concerns and subsequent resignation, we were unable to timely file our Annual Report on Form 10-K."
See Also: <a href="https://www.benzinga.com/insights/news/25/02/44043710/1000-invested-in-williams-companies-5-years-ago-would-be-worth-this-much-today">$1000 Invested In Williams Companies 5 Years Ago Would Be Worth This Much Today</a>
SMCI Price Action: At the time of writing, Super Micro stock is trading 0.50% lower at $42.77, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

Movers

SMCI

What's Going On With Super Micro Computer Stock Friday?

NVVE

Nuvve Holding shares are trading higher after the company was awarded a $400 million contract from the State of New Mexico

Canaccord Genuity analyst Michael Graham maintains DoubleVerify Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) with a Buy and lowers the price target from $30 to $26.

Canaccord Genuity Maintains Buy on DoubleVerify Hldgs, Lowers Price Target to $26

Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) with a Buy and lowers the price target from $23 to $15.

CMPS

Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $15

Craig-Hallum analyst Anthony Stoss maintains Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) with a Buy and lowers the price target from $12 to $9.

AIRG

Craig-Hallum Maintains Buy on Airgain, Lowers Price Target to $9

No-fault laws are one of the contributing factors to why car insurance premiums climb higher in some states. Twelve states hold these rules and demand that your insurance covers your injuries after a crash despite who caused it.
What are no-fault laws? In a typical setup, the at-fault driver's insurance picks up the tab for your damages, but in no-fault states your own policy steps in to handle your injuries, regardless of blame. This hinges on Personal Injury Protection—PIP for short—a required coverage in these states. PIP takes care of costs tied to the accident including medical bills and lost wages. States like Florida, Michigan, and New York follow this system though each have their own set of rules regarding PIP and subsequent lawsuits.
Here's a twist: no-fault states often block lawsuits for pain and suffering unless injuries hit a serious mark—like severe harm or death. The goal? Fewer court battles and, ideally, lower premiums. But does this actually work out the way it is supposed to?
Supporters say no-fault laws smooth out the claims process because your insurer pays your PIP claim directly. This supposedly cuts delays and legal tangles. Fewer lawsuits over pain and suffering could trim administrative costs for insurance companies and if those savings stack up, they might show up as lower premiums, especially where lawsuit limits hold firm.
But there's a flip side. PIP coverage often costs more than optional medical payments in fault-based states. With its wide reach—covering medical expenses, lost income, and beyond—insurers face bigger payouts. Michigan once had unlimited medical benefits under PIP, sending premiums through the roof. Recent changes let drivers pick lower limits.
Fraud adds another layer to the insurance mess. In Florida and New York, staged crashes and padded claims have jacked up PIP expenses and insurers hit with these losses hike premiums to balance the books. Additionally every injured driver in a no-fault state files a claim with their own company, boosting claim numbers compared to fault-based systems. In at fault states, the number of claims files is half as it is usually only the at fault person filing.
As we&#8217;ve mentioned, insurance premiums depend heavily on where you live. High PIP limits, like Michigan's old standard, tend to mean pricier rates. Strict lawsuit caps can often hold costs down. Fraud also continues to be a huge issue and states that are able tackle fraud effectively can keep steady premiums.
Take Florida for example. Despite aims to curb litigation, fraud and lawsuits have pushed premiums far above the national average. Michigan's recent PIP adjustments hint that scaling back coverage can lighten the load. Other factors—accident frequency, medical costs, and city density—muddy the picture further.
If you live in a no-fault state it might be a good idea to check your PIP minimums to weigh if the extra coverage makes sense. Know your state's lawsuit threshold—it sets the bar for chasing damages beyond PIP. Adding uninsured or underinsured motorist coverage can shield you from drivers with skimpy policies, though PIP steps in either way.
Solid liability coverage matters in fault based states. If you cause a wreck, you'll cover the other side's damages. Optional medical payments coverage can act like PIP, but it often caps out lower.
In conclusion, are no-fault laws a true contributor to inflating premiums? It's a mixed bag. They can streamline claims and trim lawsuits and possibly cut costs. Mandatory PIP and fraud risks can nudge rates up. The real impact depends on your state's rules and broader trends. Understand your local setup and pick a policy that fits—your budget will feel the difference.

Legal

Exclusives

Personal Finance

Insurance

General

Do No-Fault Laws Drive Up Your Car Insurance Premiums?

Canaccord Genuity analyst George Gianarikas maintains Ameresco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMRC#NYSE">AMRC</a>) with a Buy and lowers the price target from $36 to $27.

AMRC

Canaccord Genuity Maintains Buy on Ameresco, Lowers Price Target to $27

Craig-Hallum analyst George Sutton maintains Globalstar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSAT#NASDAQ">GSAT</a>) with a Buy and lowers the price target from $75 to $45.

GSAT

Craig-Hallum Maintains Buy on Globalstar, Lowers Price Target to $45

Nayax Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYAX#NASDAQ">NYAX</a>), a global commerce enablement and payments platform, has acquired UPPay, a digital payment and telemetry provider for automated <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g44040125/nayax-announces-the-acquisition-of-uppay" rel="noreferrer noopener">self-service coffee machines in Brazil.</a>
The purchase price, equating to an enterprise value of R$32.75 million (~$5.3 million), will be paid with cash on hand and includes the earnout amount of up to&nbsp;~$0.47 million.
Nayax entered the Brazilian market in 2024 when it acquired VMtecnologia, a technology provider for the automated self-service industry in Brazil. With the acquisition of UPPay, Nayax and VMtecnologia will serve more than 25,000 new unattended points of sale in Brazil.
UPPay will integrate operationally with VMtecnologia, consolidating both companies&#8217; sales, distributional, and technical expertise.
This strategic acquisition strengthens Nayax&#8217;s foothold in the Brazilian market and broadens its reach across Latin America, offering merchants a comprehensive suite of affordable payment solutions.
&#8220;UPPay&#8217;s sophisticated yet affordable platform complements our vision of empowering retailers of all sizes with real-time operational insights, streamlined payments, and seamless customer experiences,&#8221; stated Yair Nechmad, CEO and Chairman of Nayax.
As of September 30, 2024, the company had&nbsp;$89 million&nbsp;in cash and cash <a target="_blank" href="https://www.benzinga.com//node/41897468" rel="noreferrer noopener">equivalents and short-term deposits.&nbsp;</a>
Nayax&nbsp;will release its&nbsp;fourth quarter&nbsp;and 2024&nbsp;earnings on March 4, 2025.
Price Action: NYAX shares traded lower by 1.12% at $37.24 at last check Friday.
Photo via Shutterstock.

Equities

NYAX

Nayax Expands In Brazil With UPPay Acquisition, Taps Into New Payment Points

NTLA

Intellia Therapeutics shares are trading lower after JP Morgan downgraded the stock from Overweight to Neutral and cut its price target from $45 to $13. Additionally, Chardan Capital lowered its price target from $91 to $68.

Canaccord Genuity analyst Austin Moeller maintains Archer Aviation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) with a Buy and raises the price target from $13 to $13.5.

ACHR

Canaccord Genuity Maintains Buy on Archer Aviation, Raises Price Target to $13.5

MTUS

Metallus shares are trading lower after the company reported a year-over-year decrease in Q4 adjusted EPS results and worse-than-expected revenue.

On Friday, ANI Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIP#NASDAQ">ANIP</a>) reported fourth-quarter adjusted EPS of $1.63, up from $1 a year ago, beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $1.44</a>.
The company reported sales of $190.57 million, up 44.8% year over year, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g44038542/ani-pharmaceuticals-reports-record-fourth-quarter-and-full-year-2024-financial-results-and-raises-" rel="noreferrer noopener">consensus of $175.37 million</a>.
On an organic basis, excluding the acquisition of Alimera, total net revenues grew 23.8% year-over-year.
Net revenues for rare diseases, which include Cortrophin Gel, Iluvien, and Yutiq, increased by 108.5% to $87.0 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41296581/ani-pharmaceuticals-shifts-focus-from-generics-to-high-margin-brand-assets-analyst-" rel="noreferrer noopener">ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential</a>
Cortrophin Gel net revenues increased 42.3% to $59.4 million, driven by increased volume.
Iluvien and Yutiq generated net revenues of $27.6 million in the first full quarter <a target="_blank" href="https://www.benzinga.com/general/biotech/24/06/39460281/generics-player-ani-pharmaceuticals-strengthens-rare-disease-segment-with-380m-alimera-sciences-d" rel="noreferrer noopener">following the acquisition of Alimera</a>.
Net revenues for Brands increased 58.9% to $19.8 million, driven by increased demand.
Net revenues for Generic pharmaceutical products increased 9.4% to $78.6 million, driven by increased volumes in the base business and the contribution from new product launches.
The company launched five new products during the quarter and 17 for the full year. ANI&#8217;s strong R&amp;D and commercial productivity continued into the first quarter of 2025 with the launch of Prucalopride Tablets with 180 days of exclusivity.
The company says momentum has continued in the first quarter of 2025, with the number of new cases initiated reaching a new high in February.
Brands&#8217; revenues increased 58.9% to $19.8 million, driven by increased demand for certain products, which has occurred periodically over the past two years.
While this additional demand has persisted into the first quarter of 2025, the company anticipates a normalized performance thereafter for the purpose of full-year 2025 guidance.
Guidance: ANI Pharmaceuticals expects 2025 revenues of $756 million—$776 million, versus prior guidance of $739 million—$759 million and a consensus of $724.71 million.
The company expects adjusted EBITDA of $190 million-$200 million compared to prior guidance of $182 million-$192 million.
&#8220;With our business off to a strong start in 2025, particularly Cortrophin Gel, Generics, and Brands, we are raising our 2025 guidance for total net revenues and adjusted non-GAAP EBITDA,&#8221; said Nikhil Lalwani, President and CEO.
ANI Pharmaceuticals expects 2025 adjusted EPS of $6.12-$6.49 versus a consensus of $5.56.
Price Action: ANIP stock is up 10.41% at $60.26 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/02/44043253/mplx-seals-715-million-deal-for-full-control-of-bangl-pipeline-details" target="_blank" rel="noreferrer noopener">MPLX Seals $715 Million Deal For Full Control Of BANGL Pipeline: Details</a></li>
</ul>
Image via Shutterstock

Earnings

Guidance

Health Care

ANIP

ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast

Citizens Capital Markets analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNX#NASDAQ">CRNX</a>) with a Market Outperform and lowers the price target from $92 to $91.

CRNX

Citizens Capital Markets Maintains Market Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $91

Press Releases

Land Survey Industry Poised for Drone-Driven Transformation as Market Approaches $12.6 Billion

Unusual Machines Adds Electronic Speed Controller to the Blue UAS Framework

Adoption of Drones-as-a-Service Industry Explodes Along Rising Revenue Opportunities in the Billions

Unusual Machines Announces NDAA Compliant FPV Drone Camera

Unusual Machines Enters Into a Definive Agreement to Acquire Drone Software Company Aloft Technologies to Grow the American Drone Ecosystem

Integration of Emerging Technologies for Military Drone Market Presenting a Significant Growth Opportunity

Unusual Machines' FPV Camera Added to Blue UAS Framework

Leveraging Artificial Intelligence (AI) for Drone Operations Market Leading to Multi-Billion Dollar Revenue Opportunity

Red Cat Becomes First U.S.-Based Drone Manufacturer to Source Motors From Unusual Machines

Drone Technology Advancement for Performing Growing Number of Tasks and Usage Leading to Revenue Growth

AVAV

BMV:ZENA

HOVR

KTOS

ONDS

PRZO

RCAT

RGTI

SPAI

UMAC

ZENA

Aeva Technologies

Coda Octopus Group

Electro-Sensors

Evolv Technologies Holdings, Inc. - Class A Common Stock

Evolv Technologies

Focus Universal

Frequency Electronics, Inc. - Common Stock

Frequency Electronics

Identiv

nLight

Interlink Electronics, Inc. - Common Stock

Interlink Electronics

LightPath Technologies, Inc. - Class A Common Stock

LightPath Technologies

908 Devices

MultiSensor AI Holdings, Inc. - Common Stock

MultiSensor AI Holdings

Maris Tech

Microvision

NOVONIX Limited - American Depository Shares

NOVONIX

Ouster

Research Frontiers Incorporated - Common Stock

Research Frontiers

SmartRent

Sono-Tek

ScanTech AI Systems

TROOPS

Vishay Precision Group, Inc. Common Stock

Vishay Precision Group

Vuzix

Wrap Technologies

Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares

Comments

Unusual Machines

Unusual Machines (UMAC) オプション

Unusual Machines (AMEX:UMAC) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル